1.
Bong S-T, Law LN-S, Law JW-F. A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM). Prog Micobes Mol Biol [Internet]. 2019May30 [cited 2024Nov.17];2(1). Available from: https://journals.hh-publisher.com/index.php/pmmb/article/view/60